Rawcliffe Takes On Larger Role with GSK

GlaxoSmithKline (NYSE: GSK) has named Adrian Rawcliffe as senior vice president of worldwide business development and R&D, effective immediately. Rawcliffe most recently served as managing partner and president of SR One Ltd., the venture capital arm of GSK. No SR One successor has yet been named. www.gsk.com